The precise molecular mechanisms by which urate-associated genetic variants affect urate levels are unknown. Here, we tested for functional linkage of the maximally associated genetic variant rs1967017 at the PDZK1 locus to elevated PDZK1 expression. We performed expression quantitative trait loci (eQTL) and likelihood analyses and gene expression assays. Zebrafish were used to evaluate tissue-specific gene expression. Luciferase assays in HEK293 and HepG2 cells measured the effect of rs1967017 on transcription amplitude. Probabilistic Annotation Integrator analysis revealed rs1967017 as most likely to be causal and rs1967017 was an eQTL for PDZK1 in the intestine. The region harboring rs1967017 was capable of directly driving green fluorescent protein expression in the kidney, liver and intestine of zebrafish embryos, consistent with a conserved ability to confer tissue-specific expression. Small interfering RNA depletion of HNF4A reduced endogenous PDZK1 expression in HepG2 cells. Luciferase assays showed that the T allele of rs1967017 gains enhancer activity relative to the urate-decreasing C allele, with T allele enhancer activity abrogated by HNF4A depletion. HNF4A physically binds the rs1967017 region, suggesting direct transcriptional regulation of PDZK1 by HNF4A. Computational prediction of increased motif strength, together with our functional assays, suggests that the urate-increasing T allele of rs1967017 strengthens a binding site for the transcription factor HNF4A. Our and other data predict that the urate-raising T allele of rs1967017 enhances HNF4A binding to the PDZK1 promoter, thereby increasing PDZK1 expression. As PDZK1 is a scaffold protein for many ion channel transporters, increased expression can be predicted to increase activity of urate transporters and alter excretion of urate.

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddy295DOI Listing

Publication Analysis

Top Keywords

pdzk1 expression
16
allele rs1967017
12
expression
10
pdzk1
9
rs1967017
9
genetic variant
8
maximally associated
8
urate levels
8
gene expression
8
luciferase assays
8

Similar Publications

Aims: Duodenal Mucosal Resurfacing (DMR) is an endoscopic ablation technique aimed at improving glycemia in patients with type 2 diabetes mellitus (T2DM). Although the exact underlying mechanism is still unclear, it is postulated that the DMR-induced improvements are the result of changes in the duodenal mucosa. For this reason, we assessed macroscopic and microscopic changes in the duodenal mucosa induced by DMR + GLP-1RA.

View Article and Find Full Text PDF

Lipopolysaccharide (LPS) causes inflammatory cholestasis in sepsis. We investigated the role of PDZK1 in the repression of ABC transporters in LPS-induced cholestasis. Lentiviral gene transfer of PDZK1 to rats was conducted to explore its influence on cholestasis induced by LPS.

View Article and Find Full Text PDF

Hyperuricemia (HUA) is a metabolic disease arising from abnormal purine metabolism. It contributes to an increased risk of kidney damage. The present study aimed to investigate the uric acid (UA)-lowering effects of 259 isolated from yak yogurt and explore its underlying mechanisms.

View Article and Find Full Text PDF

Cell penetrable peptide nucleic acids targeting PDZK1IP1 with anti-inflammatory potential in human keratinocytes.

Bioorg Med Chem Lett

January 2025

Natural Products Research Institute, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea. Electronic address:

Article Synopsis
  • * Researchers developed modified peptide nucleic acids (PNAs) that are more soluble and permeable for cells, improving their effectiveness in laboratory tests.
  • * The modified PNAs successfully reduced PDZK1IP1 expression and decreased inflammatory responses in human skin cells, highlighting their potential in treating skin-related conditions.
View Article and Find Full Text PDF
Article Synopsis
  • The study reviews the impact of single nucleotide polymorphisms (SNPs) on how allopurinol is processed in the body to manage uric acid levels.
  • A thorough search of databases led to 17 relevant articles that identified 11 significant SNPs affecting the pharmacokinetics of both allopurinol and its active form, oxypurinol.
  • Certain SNPs linked to specific genes were found to influence allopurinol clearance and its metabolism, along with their potential roles in the regulation of uric acid levels, although some results were inconsistent across different studies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!